Strengthen the Capacity of Republican Narcology Centers on Practical Applications of Medication-Assisted Treatment Programs in the Kazakhstan, Kyrgyzstan and Tajikistan under the President's Emergency Plan for AIDS Relief (PEPFAR) | CDC RFA GH15 151502CONT16

Opportunity Information: Apply for CDC RFA GH15 151502CONT16

This grant opportunity, issued by the Centers for Disease Control and Prevention (CDC), focuses on strengthening the capacity of Republican Narcology Centers to better implement and manage medication-assisted treatment (MAT) programs in Kazakhstan, Kyrgyzstan, and Tajikistan under the President's Emergency Plan for AIDS Relief (PEPFAR). The intent is tightly tied to public health outcomes at the intersection of substance use disorders and HIV prevention and care, particularly in settings where injection drug use can be a major driver of HIV transmission. By emphasizing "practical applications" of MAT, the opportunity signals a focus on hands-on implementation support, clinical and programmatic improvement, and the institutional ability of national-level addiction treatment centers to deliver MAT effectively and consistently.

The award is structured as a cooperative agreement, which typically means CDC expects to have substantial involvement in the work rather than simply issuing funds with minimal oversight. In practice, that usually translates into close technical collaboration, shared planning, and ongoing monitoring of progress against program goals. The funding activity category is Health, and the listed CFDA number is 93.067, aligning it with CDC global health and related public health initiatives. The opportunity is categorized as a continuation, and the funding opportunity number (CDC RFA GH15 151502CONT16) indicates it is not a broad open competition but a continuation action tied to an earlier announcement.

A key limitation is eligibility: this continuation funding is intended only for organizations that were previously awarded under the earlier CDC funding opportunity CDC-RFA-GH15-1515, which had the same general purpose of strengthening Republican Narcology Centers around MAT in these three countries under PEPFAR. That means new applicants who were not part of the original award cohort would not be eligible to compete for these funds. The eligible applicants field is listed as "Others," but the narrative makes clear the practical restriction is prior awardee status under the specified predecessor announcement.

In terms of timing and administrative details, the opportunity was created on September 18, 2015, with an original closing date of March 21, 2016. The listing shows an award ceiling of 0 and no expected awards value populated, which commonly indicates that specific funding amounts are either determined internally for continuation awards, depend on appropriations and satisfactory progress, or are otherwise not being competed in a way that requires a published ceiling for new applicants. The main takeaway is that this is a continuation mechanism to keep an existing CDC-supported effort going rather than a new, open solicitation inviting fresh proposals.

Overall, the grant is best understood as CDC using PEPFAR resources to continue building real-world, operational capacity for MAT delivery within key national addiction treatment institutions in Kazakhstan, Kyrgyzstan, and Tajikistan. The continuation framing suggests the work is already underway and that the purpose of this award is to sustain and advance that existing program, likely by further improving clinical practice, staff capability, service quality, and implementation structures needed to run MAT programs effectively in support of HIV prevention and broader public health goals.

• The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Strengthen the Capacity of Republican Narcology Centers on Practical Applications of Medication-Assisted Treatment Programs in the Kazakhstan, Kyrgyzstan and Tajikistan under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on 2015-09-18.
• Applicants must submit their applications by 2016-03-21. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: Others.

Apply for CDC RFA GH15 151502CONT16

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: